logo-loader
Proactive logo live

Tonix Pharmaceuticals doses first patient in Phase 2 OASIS trial for acute...

Tonix Pharmaceuticals Holdings CEO Dr Seth Lederman joined Steve Darling from Proactive to announced that the first patient has been dosed in the Phase 2 OASIS trial, a study evaluating TNX-102 SL for reducing the severity of acute stress reaction (ASR) and preventing the onset of acute stress...

21 hours, 16 minutes ago
Insight

Treatment.com AI on front line of the quest to enhance healthcare system...

It depends on whom you ask, but healthcare in most countries feels, if not broken, then at the...

5 days, 18 hours ago
Big Caps

Rio Tinto downgraded as Jefferies flags CEO transition, capex pressures

Jefferies has downgraded Rio Tinto Ltd (LSE:RIO, ASX:RIO, OTC:RTNTF) to 'Hold' from 'Buy',...

6 days, 19 hours ago
Big Caps

Apple has Bank of America analysts bullish but bear case ‘not without merit’

Apple Inc (NASDAQ:AAPL, ETR:APC) shares are currently priced at an attractive entry point for...

1 week, 1 day ago
Psychedelics

atai Life Sciences gains maximum exposure to key psychedelic asset with...

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) stock is poised to move higher following its planned...

1 week, 1 day ago

Join Proactive

Get ahead of the curve

OSZAR »